The Recombinant Escherichia coli O9:H4 Probable Ubiquinone Biosynthesis Protein UbiB (ubiB) is a genetically engineered protein derived from Escherichia coli, specifically involved in the biosynthesis of ubiquinone, also known as coenzyme Q (CoQ). CoQ is a crucial electron carrier in the respiratory chain of bacteria and plays a significant role in cellular bioenergetics. The ubiB gene encodes a protein that is part of a predicted protein kinase family, which may have roles in activating enzymes necessary for ubiquinone biosynthesis through phosphorylation .
UbiB is essential for the first monooxygenase step in CoQ biosynthesis. Mutant strains of E. coli lacking functional UbiB accumulate octaprenylphenol, a CoQ biosynthetic intermediate, indicating its critical role in this pathway . The ubiB gene is closely linked to ubiD, another gene involved in successive reactions of ubiquinone biosynthesis .
| Feature | Description |
|---|---|
| Function | Essential for the first monooxygenase step in CoQ biosynthesis |
| Accumulated Intermediate | Octaprenylphenol in mutant strains lacking UbiB |
| Genetic Linkage | Closely linked to ubiD in E. coli |
| Protein Family | Member of a predicted protein kinase family |
Research on UbiB has highlighted its potential kinase activity, which may regulate CoQ biosynthesis by phosphorylating proteins involved in the monooxygenase steps . The ubiB gene product's possible role in differential phosphorylation during growth phases could explain why CoQ biosynthesis defects are bypassed in stationary-phase cultures . Additionally, UbiB family proteins, such as those in yeast, have been implicated in mitochondrial morphology and phospholipid homeostasis .
| Protein | Organism | Function |
|---|---|---|
| UbiB | E. coli | Essential for CoQ biosynthesis, potential kinase activity |
| Cqd1 | Yeast | Forms membrane contact sites, regulates CoQ distribution |
| Cqd2 | Yeast | Influences mitochondrial CoQ levels, involved in lipid homeostasis |
Understanding the precise mechanisms by which UbiB and related proteins function is crucial for elucidating CoQ biosynthesis and its regulation. The development of small-molecule inhibitors for UbiB family proteins, such as COQ8, could provide insights into their roles in disease and offer therapeutic strategies . Further research is needed to explore how these proteins influence cellular CoQ distribution and lipid metabolism.
KEGG: ecx:EcHS_A4059
UbiB is one of at least eleven proteins involved in ubiquinone (coenzyme Q) biosynthesis in Escherichia coli. It functions as a hydroxylase that introduces a hydroxyl group at specific positions of the benzene nucleus during ubiquinone synthesis . The UbiB protein is classified as a "probable ubiquinone biosynthesis protein," indicating its essential role in the electron transport chain when oxygen or nitrate serves as the electron acceptor .
Structurally, E. coli UbiB is a 546-amino acid protein that belongs to a family of proteins involved in energy metabolism . The ubiquinone pathway in E. coli involves multiple sequential reactions, and UbiB specifically participates in one of the three hydroxylation steps required for the modification of the aromatic ring structure of ubiquinone precursors .
The ubiB gene is located at the 87-minute position on the Escherichia coli linkage map . This chromosomal location is significant for understanding the genetic organization of ubiquinone biosynthesis genes in E. coli. Interestingly, genetic mapping studies have shown that another ubiquinone biosynthesis gene, ubiD, is closely linked to ubiB . This genetic proximity suggests potential co-regulation or functional relationships between these genes in the ubiquinone biosynthetic pathway.
UbiB functions within a complex network of proteins involved in ubiquinone biosynthesis. Research using bacterial two-hybrid systems has demonstrated that UbiB can interact with UbiK . Specifically, UbiK was found to interact with UbiB when UbiK was fused to the T18 moiety in bacterial two-hybrid reporter systems .
This interaction appears to be part of a larger interaction network, as UbiK has been shown to interact with multiple other Ubi proteins including UbiE, UbiF, UbiG, UbiH, UbiI, UbiJ, and UbiX . These interactions suggest that ubiquinone biosynthesis likely involves multiprotein complexes rather than isolated enzymatic reactions, which may be important for channeling intermediates through the pathway efficiently.
Mutations in the ubiB gene lead to deficiencies in ubiquinone production in E. coli. These mutants exhibit impaired growth on substrates that require a functional electron transport chain, such as succinate . Since ubiquinone plays an essential role in aerobic and nitrate respiration, ubiB mutants show growth defects under conditions where these respiratory pathways are required.
Complementation studies have demonstrated that introducing a functional ubiB gene into mutant strains restores their ability to synthesize ubiquinone and grow on respiratory substrates . This confirms the direct involvement of UbiB in the ubiquinone biosynthetic pathway and its importance for respiratory metabolism in E. coli.
The exact molecular mechanism of UbiB's hydroxylase activity remains incompletely characterized. UbiB is involved in introducing a hydroxyl group to the benzene nucleus of ubiquinone precursors, but the specific biochemical details of this reaction have not been fully elucidated . Unlike typical monooxygenases that require molecular oxygen, there is evidence suggesting that UbiB may participate in an oxygen-independent hydroxylation process under certain conditions .
Recent research on UbiUV-dependent ubiquinone synthesis has shown that some hydroxylation steps in the ubiquinone pathway can occur through unique O₂-independent processes . Genetic studies and ¹⁸O₂ labeling experiments have revealed that proteins like UbiUV contribute to the hydroxylation of ubiquinone precursors in the absence of oxygen . This raises intriguing questions about whether UbiB might also have dual functionality under different oxygen conditions, potentially utilizing alternative electron acceptors or hydroxyl group sources when oxygen is limited.
This anaerobic pathway represents a novel mechanism for ubiquinone synthesis in the absence of oxygen. Research has shown that UbiUV-dependent ubiquinone synthesis is essential for nitrate respiration and uracil biosynthesis under anaerobiosis, and it contributes to bacterial multiplication in the mouse gut . The relationship between the traditional UbiB-dependent aerobic pathway and this alternative anaerobic pathway remains an active area of research. Understanding how these pathways interact and are regulated under different oxygen conditions is crucial for comprehending E. coli's metabolic flexibility.
The connection between ubiquinone biosynthesis and bacterial pathogenesis is an emerging area of research. Studies have shown that in Salmonella enterica, another factor involved in ubiquinone biosynthesis (UbiK) is required for proliferation in macrophages and virulence in mice . Given UbiB's critical role in ubiquinone production and its interaction with UbiK, it likely also contributes to pathogenesis.
Ubiquinone biosynthesis appears to be a major driver in the capacity of E. coli to multiply in gut microbiota and of facultative anaerobic pathogens to multiply in their hosts . The ability to synthesize ubiquinone under both aerobic and anaerobic conditions may provide metabolic flexibility that contributes to bacterial survival and virulence in host environments. This link between respiratory mechanisms and phenotypic adaptation has implications for understanding how pathogenic bacteria adapt to changing oxygen levels during infection.
While the specific post-translational modifications of UbiB have not been extensively characterized in the available search results, understanding such modifications is critical for fully elucidating UbiB's function. Research on other Ubi proteins suggests that protein modifications and protein-protein interactions play important roles in regulating ubiquinone biosynthesis.
For example, studies have shown that UbiK forms a complex with UbiJ, and this interaction involves the C-terminal part of UbiJ . Similar interactions or modifications might regulate UbiB activity. Investigating potential phosphorylation, acetylation, or other modifications of UbiB under different growth conditions would provide insights into how the ubiquinone biosynthetic pathway is regulated at the post-translational level.
For expressing and purifying recombinant UbiB protein, researchers should consider the following methodological approach:
Expression system selection: E. coli BL21(DE3) or similar strains are commonly used for expressing bacterial proteins. For UbiB, which is a membrane-associated protein, specialized expression strains designed for membrane proteins may yield better results.
Vector design: Based on available information about UbiB, using vectors with inducible promoters (like T7) and appropriate fusion tags (such as His₆, MBP, or GST) can facilitate purification . The full-length UbiB protein (amino acids 1-546) should be expressed .
Culture conditions: Initial expression tests should compare different induction temperatures (16°C, 25°C, 30°C), IPTG concentrations (0.1-1.0 mM), and induction times (4-24 hours) to optimize protein yield and solubility.
Purification strategy: For His-tagged UbiB, nickel-nitrilotriacetic acid resin purification in buffer containing detergents (such as DDM or LDAO) is recommended to maintain protein solubility . Size-exclusion chromatography can be used as a polishing step.
Storage conditions: Purified UbiB should be stored in Tris-based buffer with 50% glycerol at -20°C for short-term storage or -80°C for extended storage, avoiding repeated freeze-thaw cycles .
Assessing UbiB enzymatic activity requires specialized approaches due to its involvement in hydroxylation reactions within the ubiquinone biosynthetic pathway:
Substrate preparation: Synthetic or isolated ubiquinone precursors such as 2-octaprenylphenol or related intermediates should be prepared as substrates .
Activity assays: Hydroxylase activity can be measured using:
Detection methods: UV-visible spectrophotometry at specific wavelengths characteristic of ubiquinone intermediates, or mass spectrometry to identify specific hydroxylated products.
Controls: Include positive controls (known hydroxylases) and negative controls (heat-inactivated enzyme) to validate assay performance.
Cofactor requirements: Assess dependence on potential cofactors such as NAD(P)H, FAD, iron, or other metal ions that might be required for hydroxylase activity.
To generate and characterize ubiB mutants, researchers can employ the following methodological approaches:
Mutagenesis strategies:
CRISPR-Cas9 genome editing for precise modifications
Lambda Red recombineering for gene deletion or replacement
Site-directed mutagenesis for specific amino acid changes
Random mutagenesis using error-prone PCR followed by selection
Screening methods:
Complementation assays:
Phenotypic characterization:
Biochemical analysis:
Several techniques can be employed to study UbiB protein-protein interactions in the ubiquinone biosynthetic pathway:
Bacterial two-hybrid (BACTH) system:
Co-immunoprecipitation (Co-IP):
Express epitope-tagged UbiB (e.g., His₆-tag, FLAG-tag) in E. coli
Isolate protein complexes using tag-specific antibodies
Identify interacting partners by mass spectrometry or western blotting
Pull-down assays:
Yeast two-hybrid system:
Cross-linking coupled with mass spectrometry:
Treat cells or purified proteins with cross-linking agents
Digest and analyze by mass spectrometry to identify interaction sites
Provides spatial information about protein proximities
Differentiating between direct and indirect effects of ubiB mutations requires systematic analytical approaches:
Complementation analysis:
Metabolomic profiling:
Global gene expression analysis:
Conduct RNA-seq to identify transcriptional changes in ubiB mutants
Look for compensatory responses or stress signatures
Compare with expression profiles of other ubi gene mutants
Suppressor mutation analysis:
Isolate suppressor mutations that restore growth in ubiB mutants
Identify genes that can bypass UbiB function
Map genetic interactions within the ubiquinone pathway
Time-course experiments:
Monitor phenotypic and metabolic changes at different time points after shifting to restrictive conditions
Distinguish primary (rapid) from secondary (delayed) effects of ubiB inactivation
Several bioinformatic tools and approaches are valuable for analyzing UbiB structure and function:
Sequence analysis tools:
Multiple sequence alignment (MUSCLE, Clustal Omega) to identify conserved residues across species
Phylogenetic analysis to trace evolutionary relationships among UbiB homologs
Domain prediction (PFAM, InterPro) to identify functional domains
Structure prediction:
AlphaFold2 or RoseTTAFold for generating protein structure models
Molecular dynamics simulations to study protein flexibility and substrate interactions
Docking simulations to predict protein-substrate or protein-protein interactions
Functional prediction:
Gene ontology (GO) enrichment analysis
Protein-protein interaction network analysis using STRING or similar databases
Co-expression analysis to identify functionally related genes
Comparative genomics:
Analysis of gene neighborhoods across bacterial species
Identification of conserved operons or regulons
Correlation of UbiB presence with ubiquinone production across bacterial taxa
Motif analysis:
Identification of conserved sequence motifs related to enzymatic activity
Prediction of catalytic sites and residues
Analysis of potential post-translational modification sites
Distinguishing between aerobic and anaerobic ubiquinone biosynthesis pathways requires specialized experimental approaches:
Isotope labeling experiments:
Genetic approaches:
Analytical methods:
Use HPLC, LC-MS, or GC-MS to separate and identify pathway-specific intermediates
Develop targeted assays for specific pathway markers
Compare metabolite profiles between conditions using metabolomics
Time-course analysis:
Functional analysis:
When analyzing UbiB expression data across different experimental conditions, researchers should consider these statistical approaches:
Differential expression analysis:
For RNA-seq data: DESeq2, edgeR, or limma-voom
For protein expression: limma for proteomics data
Appropriate normalization methods based on data distribution
Multiple testing correction:
Benjamini-Hochberg procedure for controlling false discovery rate
Bonferroni correction for stringent control of family-wise error rate
q-value estimation for large-scale analyses
Correlation analysis:
Pearson correlation for parametric relationships
Spearman or Kendall correlation for non-parametric relationships
Correlation networks to identify co-expression patterns with other Ubi proteins
Time-series analysis:
Smoothing techniques for temporal expression data
Autoregressive integrated moving average (ARIMA) models
Principal component analysis for identifying major sources of variation
Multivariate analysis:
Principal component analysis (PCA) or t-SNE for dimension reduction
Hierarchical clustering to identify condition-specific expression patterns
Partial least squares discriminant analysis (PLS-DA) for separating experimental groups
Despite significant progress in understanding ubiquinone biosynthesis, several critical gaps remain in our knowledge of UbiB function:
The precise biochemical mechanism of UbiB-mediated hydroxylation remains incompletely characterized. While UbiB is known to be involved in hydroxylation reactions during ubiquinone synthesis, the exact catalytic mechanism, including cofactor requirements and reaction intermediates, requires further investigation .
The three-dimensional structure of UbiB has not been determined experimentally, limiting our understanding of its catalytic site and substrate interactions. Structural studies would provide valuable insights into how UbiB recognizes and processes its substrates.
The regulatory mechanisms controlling UbiB expression and activity under different environmental conditions remain poorly understood. While some ubiquinone biosynthesis genes are known to be regulated by oxygen-sensing factors like Fnr , the specific regulation of UbiB requires further clarification.
The relationship between UbiB and the anaerobic ubiquinone biosynthesis pathway mediated by UbiUVT needs further exploration. Understanding how these pathways interact or compensate for each other would provide a more complete picture of ubiquinone biosynthesis regulation .
The potential role of UbiB in bacterial pathogenesis and host-microbe interactions remains an understudied area that warrants further investigation, particularly given the importance of ubiquinone in bacterial adaptation to diverse environments .
Several emerging technologies hold promise for advancing our understanding of UbiB and ubiquinone biosynthesis:
Cryo-electron microscopy could enable determination of the three-dimensional structure of UbiB and its complexes with other Ubi proteins, providing insights into the molecular organization of the ubiquinone biosynthetic machinery.
Single-cell metabolomics techniques would allow researchers to investigate cell-to-cell variability in ubiquinone biosynthesis and its regulation under different environmental conditions.
Genome-wide CRISPR screens could identify previously unknown genes affecting ubiquinone biosynthesis and reveal synthetic interactions with ubiB and other ubi genes.
Advanced protein labeling and imaging techniques, such as proximity labeling combined with mass spectrometry, would provide detailed maps of the protein interaction networks involving UbiB in living cells.
Systems biology approaches integrating multi-omics data (transcriptomics, proteomics, metabolomics) could reveal how UbiB function is coordinated with broader cellular processes and how ubiquinone biosynthesis responds to environmental changes.